Phase 4 Studies in India: Post-Approval Commitments Explained
Phase 4 Studies in India: Post-Approval Commitments Explained Understanding Phase IV Clinical Trials in India and Post-Marketing Regulatory Responsibilities Introduction Phase IV or post-marketing clinical studies are a crucial component of India’s drug regulatory framework, offering real-world insights into the safety, efficacy, and optimal use of a drug after it has received market authorization. These…
Read More “Phase 4 Studies in India: Post-Approval Commitments Explained” »